CVM

CEL SCI
AMEX

Real-time Quotes | Nasdaq Last Sale

12.86
-0.19
-1.46%
Opening 10:53 08/14 EDT
OPEN
13.05
PREV CLOSE
13.05
HIGH
13.06
LOW
12.42
VOLUME
100.31K
TURNOVER
--
52 WEEK HIGH
18.00
52 WEEK LOW
6.00
MARKET CAP
496.71M
P/E (TTM)
-14.1040
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CVM stock price target is 23.00 with a high estimate of 23.00 and a low estimate of 23.00.

EPS

CVM News

More
CEL-SCI Q3 EPS $(0.27) Up From $(0.37) YoY
CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.27) per share. This is a 27.03 percent increase over losses of $(0.37) per share from the same period last year.
Benzinga · 3d ago
Cel-Sci up 5% on positive data on COVID-19 conjugates
Seeking Alpha · 07/24 16:35
CEL-SCI Announces Early Results with COVID 19 LEAPS Vaccine/Treatment
CEL-SCI Announces Early Results with COVID 19 LEAPS Vaccine/Treatment.
Business Wire · 07/24 12:30
Stocks To Watch: Bank Earnings And SPAC Deals Blaze In
Seeking Alpha - Article · 07/11 12:25
Cel-Sci Management May Not Be As Confident In Multikine As They Appear To Be
Seeking Alpha - Article · 07/07 17:44
CEL-SCI Corporation Receives $10 Million Through Warrant Exercises
Business Wire · 06/30 13:30
CEL-SCI Corporation Receives $10M Through Warrant Exercises
Benzinga · 06/30 12:37
CEL-SCI to Present at H.C. Wainwright Virtual Fireside Chat Series
Business Wire · 06/24 15:00

Industry

Biotechnology & Medical Research
-0.39%
Pharmaceuticals & Medical Research
-0.11%

Hot Stocks

Symbol
Price
%Change

About CVM

CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for treatment of certain head and neck cancers, and anal warts or cervical dysplasia in human immunodeficiency virus and human papillomavirus co-infected patients and Ligand Epitope Antigen Presentation System (L.E.A.P.S.) technology, with over two investigational therapies, LEAPS-H1N1-DC, a product candidate under development for treatment of pandemic influenza in hospitalized patients, and CEL-2000 and CEL-4000, vaccine product candidates under development for treatment of rheumatoid arthritis.
More

Webull offers kinds of CEL-SCI Corporation stock information, including AMEX:CVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CVM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CVM stock methods without spending real money on the virtual paper trading platform.